Rx (Prescription Medicine)
USD $ 30.00
USD $ 1.07 per tablet
Hepcinat 400 Mg 是一种高效的抗病毒药物，用于治疗慢性乙型肝炎C病毒感染。其活性成分是索非布韦（Sofosbuvir），一种强效抑制乙型肝炎C病毒（HCV）NS5B聚合酶的药物，该酶是病毒复制所必需的酶。通过抑制该酶，索非布韦可阻止病毒在体内增殖和传播，最终实现病毒清除。
Hepcinat 400 Mg 通常作为联合治疗方案的一部分，与其他抗病毒药物联合使用，具体方案取决于乙型肝炎C病毒的特定基因型和患者的既往病史。常规剂量为每日口服一次400 mg片剂，可与餐食同服或空腹服用。务必遵医嘱完成全疗程，以确保最佳治疗效果并防止耐药性产生。
常见不良反应可能包括疲劳、头痛、恶心和失眠。少见但更严重的不良反应也可能发生，因此如出现任何异常症状，请立即向医生报告。Hepcinat 400 Mg 应储存在室温下，避免潮湿和直接热源。请放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Strength | |
| Brand Name | |
| Molecule | |
| Strength | 400 mg |
| Medicine Form | Tablet |
| Pack Quantity | 28 Tablets |
| Packaging Type | Strip |
| Medicine Type | Generic |
| Country Of Origin | India |
| Rx Status | Rx (Prescription Medicine) |
其他品牌的 Sofosbuvir 400 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
